Literature DB >> 25362088

Can you ever collect too many oocytes?

Rosalind Briggs1, Gabor Kovacs2, Vivien MacLachlan3, Caroline Motteram3, H W Gordon Baker4.   

Abstract

STUDY QUESTION: Does the chance of pregnancy keep improving with increasing number of oocytes, or can you collect too many? SUMMARY ANSWER: Clinical pregnancy (CP) and live birth (LB) rates per embryo transfer varied from 10.2 and 9.2% following one oocyte collected to 37.7 and 31.3% when >16 oocytes were collected. Regression modelling indicated success rates increased or at least stayed the same with number of oocytes collected. WHAT IS KNOWN ALREADY: It has been suggested that if >15 oocytes are collected, the success rate for fresh embryo transfers decreases. As this is counterintuitive, as more oocytes should result in more embryos, with a better choice of quality embryos, we decided to analyse the recent experience in a busy IVF unit. STUDY DESIGN, SIZE DURATION: A retrospective analysis of clinical pregnancy and live birth outcome, with respect to number of oocytes collected at Monash IVF for the 2-year period between August 2010 and July 2012, where patients under the age of 45 years underwent a fresh embryo transfer. This included 7697 stimulated cycles for IVF and ICSI. PARTICIPANT/MATERIALS, SETTING,
METHODS: Statistical analysis involved data tables and graphs comparing oocyte number with outcome. Results of women who had their first oocyte collection with an embryo transfer within the reference period were analysed by logistic regression analysis including other covariates that might influence pregnancy outcome. Analysis was also carried out of all the 7679 oocyte collections undertaken, resulting in fresh embryo transfers by generalized estimating equations to allow for the within subject correlation in outcomes for repeated treatments. MAIN RESULTS AND THE ROLE OF CHANCE: The number of oocytes collected varied from 1 to 48. Clinical pregnancy and live birth rates per embryo transfer varied from 10.2 and 9.2% when only one oocyte was collected to 37.7 and 31.3% when >16 oocytes were collected. Regression modelling indicated success rates increased or at least stayed the same or with the number of oocytes collected. The percentage of women with embryos cryopreserved increased from under 20% with <4 oocytes collected to over 70% with >16 oocytes collected. There was a slight increase (from 18 to 22%) in oocyte immaturity and a more marked increase (from 0 to 3%) in cancelling fresh transfers to prevent Ovarian Hyperstimulation Syndrome (OHSS) with increase in number of oocytes collected above 16. The results of this study suggest that you cannot collect too many oocytes as both clinical pregnancy and live birth rates do not decrease with high numbers of oocytes collected. However, once >15 oocytes are collected, everything gets quite uncertain. LIMITATIONS, REASONS FOR CAUTION: As the data become sparse above 15 oocytes, we could not demonstrate a significant increase in pregnancy rates above this number. Larger studies would be required to answer the question whether there is a plateau, or rates continue to increase. The negative of aggressive stimulation to produce many oocytes is that the risk of OHSS increases, and this is the most serious complication of ovarian stimulation. STUDY FUNDING/COMPLETING OF INTERESTS: No funding was required. There is no conflict of interest, except that G.K., V.M. and C.M. are shareholders in Monash IVF Pty Ltd.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  oocyte numbers; ovarian stimulation; pregnancy rate

Mesh:

Year:  2014        PMID: 25362088     DOI: 10.1093/humrep/deu272

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  17 in total

1.  Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.

Authors:  Philippe Merviel; Michel Menard; Rosalie Cabry; Florence Scheffler; Emmanuelle Lourdel; Marie-Thérèse Le Martelot; Sylvie Roche; Jean-Jacques Chabaud; Henri Copin; Hortense Drapier; Moncef Benkhalifa; Damien Beauvillard
Journal:  Reprod Sci       Date:  2020-09-04       Impact factor: 3.060

2.  Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.

Authors:  Yuan-hui Chen; Xiao-hang Xu; Qian Wang; Shao-di Zhang; Li-le Jiang; Cui-lian Zhang; Zhao-jia Ge
Journal:  J Assist Reprod Genet       Date:  2015-09-17       Impact factor: 3.412

3.  Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.

Authors:  Alberto Revelli; Grazia Pettinau; Gemma Basso; Andrea Carosso; Alessandro Ferrero; Cecilia Dallan; Stefano Canosa; Gianluca Gennarelli; Daniela Guidetti; Claudia Filippini; Chiara Benedetto
Journal:  Reprod Biol Endocrinol       Date:  2015-07-25       Impact factor: 5.211

4.  Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.

Authors:  Danilo Cimadomo; Alberto Vaiarelli; Silvia Colamaria; Elisabetta Trabucco; Carlo Alviggi; Roberta Venturella; Erminia Alviggi; Ramona Carmelo; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Hum Reprod       Date:  2018-08-01       Impact factor: 6.918

5.  Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure.

Authors:  Anne E Martini; Sue Jasulaitis; Louis F Fogg; Meike L Uhler; Jennifer E Hirshfeld-Cytron
Journal:  J Hum Reprod Sci       Date:  2018 Jul-Sep

Review 6.  Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

Authors:  Filippo Maria Ubaldi; Danilo Cimadomo; Alberto Vaiarelli; Gemma Fabozzi; Roberta Venturella; Roberta Maggiulli; Rossella Mazzilli; Susanna Ferrero; Antonio Palagiano; Laura Rienzi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-20       Impact factor: 5.555

Review 7.  The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.

Authors:  Bruno Lunenfeld; Wilma Bilger; Salvatore Longobardi; Veronica Alam; Thomas D'Hooghe; Sesh K Sunkara
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-03       Impact factor: 5.555

8.  Use of Cumulative Live Birth Rate per Total Number of Embryos to Calculate the Success of IVF in Consecutive IVF Cycles in Women Aged ≥35 Years.

Authors:  Meng Zhang; Tao Bu; Haiqing Tian; Xia Li; Duolao Wang; Xiaohui Wan; Qingli Wang; Xinmin Mao; Xiaolin La
Journal:  Biomed Res Int       Date:  2019-06-26       Impact factor: 3.411

9.  Zeta Sperm Selection Improves Pregnancy Rate and Alters Sex Ratio in Male Factor Infertility Patients: A Double-Blind, Randomized Clinical Trial.

Authors:  Mohammad Hossein Nasr Esfahani; Mohammad Reza Deemeh; Marziyeh Tavalaee; Mohammad Hadi Sekhavati; Hamid Gourabi
Journal:  Int J Fertil Steril       Date:  2016-06-01

10.  Ovarian Sensitivity Index (OSI): Validating the Use of a Marker for Ovarian Responsiveness in IVF.

Authors:  Vikas Yadav; Neena Malhotra; Reeta Mahey; Neeta Singh; Alka Kriplani
Journal:  J Reprod Infertil       Date:  2019 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.